Clinical Trial Update: Factors Affecting PrEP Adherence

View source ↗

Summary

A completed clinical trial from UNC-Chapel Hill examined factors influencing adherence to HIV pre-exposure prophylaxis (PrEP). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV Infection | Status: COMPLETED